Cargando…
A Peptide Targeted Contrast Agent Specific to Fibrin-Fibronectin Complexes for Cancer Molecular Imaging with MRI
[Image: see text] A peptide targeted contrast agent, CLT1-(Gd-DTPA), was synthesized for molecular imaging of fibronectin−fibrin complexes in tumor tissue with magnetic resonance imaging (MRI). The T(1) and T(2) relaxivities of CLT1-(Gd-DTPA) were 4.22 and 4.45 mM(−1) s(−1) at 3 T, respectively. The...
Autores principales: | Ye, Furong, Jeong, Eun-Kee, Jia, Zhanjun, Yang, Tianxin, Parker, Denis, Lu, Zheng-Rong |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2008
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2651601/ https://www.ncbi.nlm.nih.gov/pubmed/19053180 http://dx.doi.org/10.1021/bc800211r |
Ejemplares similares
-
A Peptide Targeted Contrast Agent Specific to Fibrin−Fibronectin
Complexes for Cancer Molecular Imaging with MRI
por: Ye, Furong, et al.
Publicado: (2009) -
MRI detection of breast cancer micrometastases with a fibronectin-targeting contrast agent
por: Zhou, Zhuxian, et al.
Publicado: (2015) -
Changes of plasma fibronectin and fibronectin-fibrin complexes in dams of stillborn dairy calves
por: Jawor, Paulina, et al.
Publicado: (2020) -
Analysis of Soluble Molecular Fibronectin-Fibrin Complexes and EDA-Fibronectin Concentration in Plasma of Patients with Atherosclerosis
por: Lemańska-Perek, Anna, et al.
Publicado: (2016) -
Peptide-Based Soft Hydrogels Modified with Gadolinium Complexes as MRI Contrast Agents
por: Gallo, Enrico, et al.
Publicado: (2020)